Skip to main content

Peer Review reports

From: Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial

Original Submission
28 Jun 2023 Submitted Original manuscript
4 Dec 2023 Reviewed Reviewer Report - Michel Vaillant
3 Jun 2024 Reviewed Reviewer Report
18 Jun 2024 Author responded Author comments - Hasini Banneheke
Resubmission - Version 2
18 Jun 2024 Submitted Manuscript version 2
19 Jun 2024 Author responded Author comments - Hasini Banneheke
Resubmission - Version 3
19 Jun 2024 Submitted Manuscript version 3
24 Jun 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
25 Jun 2024 Editorially accepted
22 Jul 2024 Article published 10.1186/s12879-024-09563-y

You can find further information about peer review here.

Back to article page